SEARCH

SEARCH BY CITATION

References

  • Andrew M., Paes B., Milner R., Johnston M., Mitchell L., Tollefsen D.M. & Powers P. (1987) Development of the human coagulation system in the full-term infant. Blood 70, 165172.
  • Andrew M., Vegh P., Johnston M., Bowker J., Ofosu F. & Mitchell L. (1992) Maturation of the hemostatic system during childhood. Blood 80, 19982005.
  • Baglin T., Gray E., Greaves M., Hunt B.J., Keeling D., Machin S., Mackie I., Makris M., Nokes T., Perry D., Tait R.C., Walker I. & Watson H. (2010) Clinical guidelines for testing for heritable thrombophilia. BJH 149, 209220.
  • Bovill E.G., Tomczak J.A., Grant B., Bhushan F., Pillemer E., Rainville I.R. & Long G.L. (1992) Protein C Vermont: symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood 79, 14561465.
  • Buil A., Soria J.M., Souto J.C., Almasy L., Lathrop M., Blangero J. & Fontcuberta J. (2004) Protein C levels are regulated by a quantitative trait locus on chromosome 16: results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. Arteriosclerosis, Thrombosis, and Vascular Biology 24, 13211325.
  • Castoldi E. & Rosing J. (2010) APC resistance: biological basis and acquired influences. Journal of Thrombosis and Haemostasis 8, 445453.
  • Chalmers E., Cooper P., Forman K., Grimley C., Khair K., Minford A., Morgan M. & Mumford A. (2011) Purpura fulminans: recognition, diagnosis and management. Archives of Disease in Childhood 96, 10661071.
  • Cooper P.C., Cooper S.M., Goodfellow K.J., Hickey K.P., Kitchen S. & Makris M. (2008) Evaluation of a new venom-based clotting assay of protein C. International Journal of Laboratory Hematology 30, 437443.
  • Cooper P.C., Siddiq S., Morse C., Nightingale J. & Mumford A.D. (2011) Marked discrepancy between coagulometric Protein C activity assays with the pro-thrombotic Protein C Asn2Ile substitution. International Journal of Laboratory Hematology 33, 451456.
  • Crawley J.T.B. (2007) Multiple roles of the endothelial cell protein C receptor. Journal of Thrombosis and Haemostasis 5, 18131816.
  • Dahlback B. (2008) Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 112, 1927.
  • D’Angelo S.V., Gilardoni F. & D’Angelo A. (1989) Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S. Thrombosis and Haemostasis 62, 861867.
  • Dolan G., Neal K., Cooper P., Brown P. & Preston F.E. (1994) Protein C, antithrombin III and plasminogen: effect of age, sex and blood group. British Journal Haematology 86, 798803.
  • Favaloro E.J., Lippi G. & Adcock D.M. (2008) Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Seminars in Thrombosis and Hemostasis 34, 612634.
  • Flanders M.M. & Rodgers G.M.. (2004) Evaluation of a Russell’s viper venom-based protein C assay. Thrombosis and Haemostasis 92, 430431.
  • Foster D.C., Yoshitake S. & Davie E.W. (1985) The nucleotide sequence of the gene for human protein C. Proceedings of the National Academy of Sciences of the United States of America 82, 46734677.
  • Gardiner C., Cooper P.C., Makris M., Mackie I.J., Malia R.G. & Machin S.J. (2002) An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity. Blood Coagulation and Fibrinolysis 13, 155163.
  • Gempeler-Messina P.M., Volz K., Buhler B. & Muller C. (2001) Protein C activators from snake venoms and their diagnostic use. Haemostasis 31, 266272.
  • Goldenberg N.A. & Manco-Johnson M.J. (2008) Protein C deficiency. Haemophilia 14, 12141221.
  • Henkens C.M., van der Meer J., Hillege J.L., van der Schaaf W., Bom V.J. & Halie M.R. (1993) The clinical expression of hereditary protein C and protein S deficiency: a relation to clinical thrombotic risk factors and to levels of protein C and protein S? Blood Coagulation & Fibrinolysis 4, 555562.
  • Hubbard A.R. (1988) Standardization of protein C in plasma: establishment of an international standard. Thrombosis and Haemostasis 59, 464467.
  • de Jager W., Prakken B.J., Bijlsma J.W., Kuis W. & Rijkers G.T. (2005) Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. Journal of Immunological Methods 300, 124135.
  • Jennings I., Kitchen S., Cooper P.C., Rimmer J.E., Woods T.A.L. & Preston F.E. (2000) Further evidence that Activated Protein C Resistance affects Protein C coagulant activity assays. Thrombosis and Haemostasis 83, 171172.
  • Jennings I., Kitchen S., Woods T.A. & Preston F.E. (2005) Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program. Seminars in Thrombosis and Hemostasis 31, 6672.
  • Khor B. & Van Cott E.M. (2010) Laboratory tests for protein C deficiency. American Journal of Hematology 85, 440442.
  • Koeleman B.P., Reitsma P.H. & Bertina R.M. (1997) Familial thrombophilia: a complex genetic disorder. Seminars in Hematology 34, 256264.
  • Koeleman B.P., Reitsma P.H., Allaart C.F. & Bertina R.M. (1994) Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 84, 10311035.
  • van Korlaar I.M., Vossen C.Y., Rosendaal F.R., Bovill E.G., Naud S., Cameron L.D. & Kaptein A.A. (2005) Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency. Journal of Thrombosis & Haemostasis 3, 24372444.
  • Kottke-Marchant K. & Comp P. (2002) Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Archives of Pathology and Laboratory Medicine 126, 13371348.
  • Kovacs M.J., Kovacs J., Anderson J., Rodger M.A., Mackinnon K. & Wells P.S. (2006) Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism. Clinical & Laboratory Haematology 28, 913.
  • Kuismanen K., Levo A., Vahtera E., Rasi V., Labrouche S., Freyburger G., Krusius T. & Partanen J. (2006) Genetic background of type I protein C deficiency in Finland. Thrombosis Research 118, 603609.
  • Lippi G., Blanckaert N., Bonini P., Green S., Kitchen S., Palicka V., Vassault A.J., Mattiuzzi C. & Plebani M. (2009) Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics. Clinical Chemistry and Laboratory Medicine 47, 143153.
  • Lyall H., Hill M., Cooper P., Forman K. & Dolan G. (2008) Limitations of the chromogenic protein C assay illustrated by a case of neonatal purpura fulminans. British Journal Haematology 141(Suppl 1), 74.
  • Mackie I.J., Gallimore M. & Machin S.J. (1992) Contact factor proteases and the complexes formed with alpha 2-macroglobulin can interfere in protein C assays by cleaving amidolytic substrates. Blood Coagulation and Fibrinolysis 3, 589595.
  • Malm J., Laurell M. & Dahlbäck B. (1988) Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. British Journal Haematology 68, 437443.
  • Marlar R.A., Adcock D.M. & Madden R.M. (1990) Hereditary dysfunctional protein C molecules (type II): assay characterization and proposed classification. Thrombosis and Haemostasis 63, 375379.
  • Meijer P., Haverkate F. & Kluft C. (2006) Performance goals for the laboratory testing of antithrombin, protein C and protein S. Thrombosis and Haemostasis 96, 584589.
  • Meijer P., Kluft C., Haverkate F. & De Maat M.P.M. (2003) The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation. Journal of Thrombosis and Haemostasis 1, 748753.
  • Mikami S. & Tuddenham E.G. (1986) Studies on immunological assay of vitamin K dependent factors. II. Comparison of four immunoassay methods with functional activity of protein C in human plasma. British Journal Haematology 62, 183193.
  • Millar D.S., Johansen B., Berntorp E., Minford A., Bolton-Maggs P., Wensley R., Kakkar V., Schulman S., Torres A., Bosch N. & Cooper D.N. (2000) Molecular genetic analysis of severe protein C deficiency. Human Genetics 106, 646653.
  • de Moerloose P., Reber G. & Bouvier C.A. (1988) Spurious low levels of protein C with a Protac activation clotting time. Thrombosis and Haemostasis 59, 543.
  • OECD (2007) Organisation for Economic Co-operation and Development (OECD) Guildeines for Quality Assurance in Molecular Genetic Testing. http://www.oecd.org/dataoecd/43/6/38839788.pdf .
  • Pabinger I., Allaart C.F., Hermans J., Briet E. & Bertina R.M. (1992) Hereditary protein C deficiency: laboratory values in transmitters and guidelines for the diagnosis procedure. Report on a study of the SSC subcommittee on protein C and protein S. Protein C transmitter group. Thrombosis and Haemostasis 68, 470474.
  • Plutzky J., Hoskins J.A., Long G.L. & Crabtree G.R. (1986) Evolution and organization of the human protein C gene. Proceedings of the National Academy of Sciences of the United States of America 83, 546550.
  • Reitsma P.H., Poort S.R., Allaart C.F., Briet E. & Bertina R.M. (1991) The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type 1: heterogeneity and founder effects. Blood 78, 890894.
  • Reitsma P.H., Bernardi F., Doig R.G., Gandrille S., Greengard J.S., Ireland H., Krawczak M., Lind B., Long G.L., Poort S.R., Saito H., Sala N., Witt I. & Cooper D.N. (1995) Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thrombosis and Haemostasis 73, 876889.
  • Rovida E., Merati G., D’Ursi P., Zanardelli S., Marino F., Fontana G., Castaman G. & Faioni E.M. (2007) Identification and computationally-based structural interpretation of naturally occurring variants of human protein C. Human Mutation 28, 345355.
  • Saah A.J. & Hoover D.R. (1997) “Sensitivity” and “specificity” reconsidered: the meaning of these terms in analytical and diagnostic settings. Annals of Internal Medicine 126, 9194.
  • Said J.M., Ignjatovic V., Monagle P.T., Walker S.P., Higgins J.R. & Brennecke S.P. (2010) Altered reference ranges for protein C and protein S during early pregnancy: implications for the diagnosis of protein C and protein S deficiency during pregnancy. Thrombosis and Haemostasis 103, 984988.
  • Spek C.A., Greengard J.S., Griffin J.H., Bertina R.M. & Reitsma P.H. (1995) Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. Journal of Biological Chemistry 270, 2421624221.
  • Stamey T.A. (1996) Lower limits of detection, biological detection limits, functional sensitivity, or residual cancer detection limit? Sensitivity reports on prostate-specific antigen assays mislead clinicians. Clinical Chemistry 42, 849852.
  • Tait R.C., Walker I.D., Islam S.I., Mitchell R., Conkie J.A., McCall F. & Davidson J.F. (1991) Age related changes in protein C activity in healthy adult males. Thrombosis and Haemostasis 65, 326327.
  • Tait R.C., Walker I.D., Reitsma P.H., Islam S.I., McCall F., Poort S.R., Conkie J.A. & Bertina R.M. (1995) Prevalence of protein C deficiency in the healthy population. Thrombosis and Haemostasis 73, 8793.
  • Takagi A., Tanaka R., Nakashima D., Fujimori Y., Yamada T., Okumura K., Murate T., Yamada M., Horikoshi Y., Yamamoto K., Katsumi A., Matsushita T., Naoe T. & Kojima T. (2009) Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations. International Journal of Hematology 89, 555557.
  • Toulon P., Halbmeyer W.M., Hafner G., Schmitt Y., Randgard B., Odpadlik M., Van Den Eynden C. & Wagner C. (2000) Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation. Blood Coagulation and Fibrinolysis 11, 447454.
  • Toulon P., Smirnov M., Triscott M., Safa O., Biguzzi E., Bouziane K. & Tripodi A. (2009) A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study. Thrombosis Research 124, 137143.
  • Tripodi A., Franchi F., Krachmalnicoff A. & Mannucci P.M. (1990) Asymptomatic homozygous protein C deficiency. Acta Haematologica 83, 152155.
  • Walker I., Greaves M. & Preston F.E. (2001) The BCSH (British Committee for Standards in Haematology) Haemostasis and Thrombosis Task Force: guideline: investigation and management of heritable thrombophilia. British Journal Haematology 114, 512528.